Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Holding(s) in Company
-
Hillsborough Leaders Remind Community to Drive Safely Around School Buses as Back-to-School Approaches Next Week
-
Tao of Trading to Reveal How to Spot Market Shifts Before They Happen in Free Live Online Event
-
Creatd CEO and Executive Chairman Jeremy Frommer Joins Blue Gold Advisory Board
-
Water Tower Research Publishes Initiation of Coverage Report on Tian Ruixiang Holdings Limited, “From Traditional Insurance Broker to Tech-Based Health Insurance Innovator”
-
Kanopy Signs on as Producer and Distributor of Newest Charlie Kaufman Short Film “How to Shoot a Ghost”
-
ATARI: Capital increase in relation to the repayment in shares of loans from IRATA LLC
-
Press release: SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
-
Mortgage Rates Continue to Decrease
-
Faster and Safer: XXKK Exchange Launches Fully Upgraded Web Platform, Delivering Smart Crypto Trading Experience in 2025
-
Faster and Safer: XXKK Exchange Launches Fully Upgraded Web Platform, Delivering Smart Crypto Trading Experience in 2025
-
HTX Hot Listings Weekly Recap (Jul 28 - Aug 4): Multi-Sector Growth Led by Meme Coin and AI Narratives
-
Fly Play hf.: Financial Results Q2 2025
-
Dairy Companies Slash Added Sugars by Nearly 60% in School Milk as New School Year Begins
-
Ethereum Daily Transactions Hit All-Time High as Little Pepe (LILPEPE) Completes Stage 9 of Presale and Launches $777K Giveaway
-
CANCELS AND REPLACES _ PR_Tarkett - 2025 Half year Financial report available
-
Publication of a transparency notification
-
Middlefield Canadian Income PCC: Net Asset Value(s)
-
Dorel Provides Update on Long-Term Debt
-
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
-
Travis Credit Union Launches $1,000 Grants for Local Teachers
-
Gray Media and Graham Media Group Raise More Than $1.1 Million Dollars for Texas Flooding Relief
-
Vaisala Corporation: Share Repurchase 7.8.2025
-
Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results
-
Just One Week Away! Register Now for the Philadelphia C-suite executives invited to HMG Strategy’s 10th Annual C-Level Technology Leadership Summit on August 14
-
TAB Bank Delivers $3.5 Million Working Capital Facility to Major North American Transportation Provider
-
Genmab Announces Financial Results for the First Half of 2025
-
Ress Life Investments A/S publishes portfolio composition for Q2 2025
-
WNC & Associates and AHP Developers, LLC Break Ground on Skyway Gardens II in Alpine, Texas
-
Chicago's Four Seasons in Tug-of-War: Summer and Winter Clash as Spring Goes Missing! What Lies Ahead for Our Weather?
-
Flutter Entertainment Announce Management Participation in Upcoming Event
-
Money Management International Partners with Colorado’s Office of Just Transition to Support Workers and Families During Coal Industry Transition
-
Shineco, Inc. to Effect 50:1 Reverse Stock Split
-
Altius Inspiro Earns Great Place To Work Certification
-
Hemp Feed Coalition Secures AAFCO Official Publication for Hemp Seed Meal in Poultry Feed
-
Chicago's Four Seasons in Tug-of-War: Summer and Winter Clash as Spring Goes Missing! What Lies Ahead for Our Weather?
-
Result of AGM
-
WeightWatchers Appoints SoulCycle Co-Founder Julie Rice as Chief Experience Officer to Lead Community and Brand Innovation
-
Urbana Corporation Has Filed 2025 Second Quarter Interim Financial Statements
-
CosMedical Technologies Appoints Keith Buchman as Vice President of Sales, Accelerating Strategic Growth and Client Partnership
-
Jellystone Park Locations Pack Their Autumn Weekends With Fall Activities and Halloween Fun
-
New Jane Doe Brings Allegations of Sexual Abuse against Tri-Cities OB-GYN Mark Mulholland
-
Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL)
-
Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL)
-
Ocean City, Maryland Bids Farewell to Summer with Travel Deals and Events
-
SKYX Announces Corporate Update Call Including New Developments
-
Minerals Technologies Inc. Announces Participation at Upcoming Investor Conferences
-
Secure Futures Obtains $15.2 Million Commitment to Finance Commercial Solar Power Projects in Virginia
-
Aggreko Partners With Western Golf Association to Support Scholarships and Veterans for Second Year
-
Alkeus Pharmaceuticals Announces Presentation of Positive Interim TEASE-3 Study Data in Early-Stage Stargardt Disease Patients Treated with Oral Gildeuretinol
